United Asset Strategies, Inc. Amgen Inc Transaction History

United Asset Strategies, Inc.

$1.07 Billion
Q3 2024

A detailed history of United Asset Strategies, Inc. transactions in Amgen Inc stock. As of the latest transaction made, United Asset Strategies, Inc. holds 31,593 shares of AMGN stock, worth $8.25 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

31,593

Previous 38,472 17.88%

Holding current value

$8.25 Million

Previous $12 Million 15.32%

% of portfolio

0.95%

Previous 1.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $2.13 Million - $2.32 Million	-6,879 Reduced 17.88%	31,593 $10.2 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $397,540 - $483,116	1,513 Added 4.09%	38,472 $12 Million
Q1 2024 Apr 23, 2024	BUY	$268.87 - $324.56 $331,516 - $400,182	1,233 Added 3.45%	36,959 $10.5 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $4.92 Million - $5.55 Million	-19,243 Reduced 35.01%	35,726 $10.3 Million
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $118,945 - $147,674	-544 Reduced 0.98%	54,969 $14.8 Million
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $231,197 - $273,386	1,079 Added 1.98%	55,513 $12.3 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $7,676 - $9,356	-34 Reduced 0.06%	54,434 $13.2 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $377,899 - $480,166	-1,650 Reduced 2.94%	54,468 $0
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $71,378 - $80,501	318 Added 0.57%	56,118 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $6,229 - $6,931	27 Added 0.05%	55,800 $13.6 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $5.14 Million - $5.68 Million	23,431 Added 72.45%	55,773 $13.5 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $246,213 - $281,768	-1,238 Reduced 3.69%	32,342 $7.28 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $431,120 - $505,109	2,031 Added 6.44%	33,580 $7.14 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $260,675 - $289,200	1,116 Added 3.67%	31,549 $7.69 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $323,322 - $376,780	1,457 Added 5.03%	30,433 $7.57 Million
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $239,749 - $285,498	1,108 Added 3.98%	28,976 $6.66 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $13,140 - $14,613	-56 Reduced 0.2%	27,868 $7.08 Million
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $188,908 - $231,816	955 Added 3.54%	27,924 $6.59 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $52,485 - $69,609	288 Added 1.08%	26,969 $5.47 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $15,326 - $19,699	-81 Reduced 0.3%	26,681 $6.43 Million
Q3 2019 Nov 01, 2019	BUY	$174.11 - $208.62 $66,335 - $79,484	381 Added 1.44%	26,762 $5.18 Million
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $49,343 - $57,841	296 Added 1.13%	26,381 $4.86 Million
Q1 2019 May 02, 2019	BUY	$180.87 - $203.88 $73,614 - $82,979	407 Added 1.59%	26,085 $4.96 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $75,998 - $88,714	426 Added 1.69%	25,678 $5 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $11,302 - $12,742	-61 Reduced 0.24%	25,252 $5.24 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $210,551 - $236,494	1,268 Added 5.27%	25,313 $4.67 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $21,348 - $24,948	126 Added 0.53%	24,045 $4.1 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $132,837 - $148,420	787 Added 3.4%	23,919 $4.16 Million
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $3.87 Million - $4.42 Million	23,132	23,132 $4.31 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Asset Strategies, Inc. with notifications on news.

Account

United Asset Strategies, Inc. Amgen Inc Transaction History